A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer-Reference-Cited by-同舟云学术

A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer

Published:2020-05-26 Issue:15 Volume:126 Page:3464-3470
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Richard D.¹^ORCID,Sanoff Hanna K.²^ORCID,Poklepovic Andrew S.³^ORCID,Soares Heloisa⁴,Kim Jongphil⁵,Lyu Jing⁶,Liu Yingmiao⁶,Nixon Andrew B.⁶,Kim Dae Won¹

Affiliation:

1. Department of Gastrointestinal Oncology Moffitt Cancer Center Tampa Florida USA

2. Department of Medicine University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill North CarolinaUSA

3. Department of Medicine Virginia Commonwealth University Health System Richmond Virginia USA

4. University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico USA

5. Department of Biostatistics and Bioinformatics Moffitt Cancer Center Tampa Florida USA

6. Department of Medicine Duke University Medical Center Durham North Carolina USA

Funder

Bayer HealthCare

H. Lee Moffitt Cancer Center and Research Institute

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32964

Reference32 articles.

1. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

2. Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas

3. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

4. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

5. ABC‐06 | A randomised phase III, multi‐centre, open‐label study of active symptom control (ASC) alone or ASC with oxaliplatin/5‐FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced/metastatic biliary tract cancers (ABC) previously‐treated with cisplatin/gemcitabine (CisGem) chemotherapy [abstract 4003];Lamarca A;J Clin Oncol,2019

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

2. Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers;Critical Reviews in Oncology/Hematology;2024-07

3. Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis;Future Oncology;2024-04

4. Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine;Cancers;2024-02-22

5. Advances in targeted therapy of cholangiocarcinoma;Annals of Medicine;2024-02-15